Cargando...

Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand

The positive predictive value of newborn screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency was <2% in New Zealand. This is despite a bloodspot second-tier immunoassay method for 17-hydroxyprogesterone measurement with an additional solvent extract step to reduce the nu...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Neonatal Screen
Main Authors: de Hora, Mark R., Heather, Natasha L., Patel, Tejal, Bresnahan, Lauren G., Webster, Dianne, Hofman, Paul L.
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2020
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7422986/
https://ncbi.nlm.nih.gov/pubmed/33073005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijns6010006
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!